We conducted a policy analysis and surveyed U.S. MOUD payment policy experts to characterize MOUD insurance coverage across major U.S. insurer categories and identify opportunities for reform and innovation. You can read the published policy analysis here.

Citation: McGinty EE, White SA, Eisenberg MD, Palmer NR, Brown CH, Saloner BK. US payment policy for medications to treat opioid use disorder: landscape and opportunities. Health Affairs Scholar. 2024;2(3). doi:10.1093/haschl/qxae024

The MOUD infographic provides an overview of the research paper. To share the image, right-click on it and select "save image as" to save the file to your computer. We encourage you to use @HEALData2Action in your Instagram and X posts in order to connect with people and organizations who are dedicated to improving MOUD treatment in the US. 

This guide describes the basics of payment policy for MOUD in the United States in 2023, including definitions of key terms and policy concepts; a summary of four domains of MOUD payment policy--coverage, provider reimbursement model, prior authorization, and co-payment requirements--across traditional Medicare, Medicare Advantage, Medicaid, and private insurance; and descriptions of three innovative payment models. Results are based on a policy analysis.